Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:9 Issue:12 Number:4 ISSN#:2563-5476
RCT
ACE Report #12649
Ace Report Cover Arthroplasty

Local TXA Reduces Blood Loss vs Intravenous TXA in Patients Undergoing Total Hip Replacement


How to Cite

OrthoEvidence. Local TXA Reduces Blood Loss vs Intravenous TXA in Patients Undergoing Total Hip Replacement . ACE Report. 2020;9(12):4. Available from: https://myorthoevidene.com/AceReport/Report/12649

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Better Treatment Values in Local Application of Tranexamic Acid (TXA) than Intravenous Application with the Same Dose in Total Hip Arthroplasty.

Adv Ther. 2020 Oct;37(10):4346-4355.

Contributing Authors: X Zhang L Wen J Pan D Ma

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Seventy-two patients scheduled for a primary, unilateral total hip replacement were randomized to receive a local administration of tranexamic acid (TXA) or intravenous administration of TXA at the same dosage. Outcomes of interest included the following: total blood loss, hidden blood loss, incidence of blood transfusion, hematocrit (Hct) and hemoglobin (Hb) levels, C-reactive protein (CRP) and i...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE

Please Login or Join to leave comments.